Taken together, these outcomes indicate that PD-L1 blockade treatment normalizes tumor vasculature and inhibits neovascularization by decreasing the expression of Tie2 and ANGPT2 through a JAK1/2-dependent mechanism. The gene discussed is CD274; the disease is neoplasm.